Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.182
+0.004 (2.19%)
At close: Nov 21, 2024, 4:00 PM
0.185
+0.003 (1.48%)
After-hours: Nov 21, 2024, 5:49 PM EST
Lyra Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 12 | 275 | 100 | 57 | 147 | - | |
| Market Cap Growth | -91.32% | 175.60% | 76.26% | -61.52% | - | - | |
| Enterprise Value | -4 | 179 | -9 | 0 | 68 | - | |
| Last Close Price | 0.18 | 5.24 | 3.14 | 4.36 | 11.40 | - | |
| PS Ratio | 7.93 | 176.78 | 73.32 | 198.95 | - | - | |
| PB Ratio | 0.58 | 3.08 | 1.24 | 1.65 | 1.98 | - | |
| P/TBV Ratio | 0.82 | 3.08 | 1.24 | 1.65 | 1.98 | - | |
| EV/Sales Ratio | - | 115.00 | - | 0.97 | - | - | |
| Debt / Equity Ratio | 1.71 | 0.30 | 0.03 | 0.04 | 0.03 | 0.45 | |
| Asset Turnover | 0.01 | 0.01 | 0.02 | 0.00 | - | - | |
| Quick Ratio | 3.45 | 5.24 | 6.77 | 2.51 | 15.27 | 1.88 | |
| Current Ratio | 3.64 | 5.35 | 6.97 | 2.63 | 15.54 | 1.94 | |
| Return on Equity (ROE) | -186.18% | -73.67% | -96.08% | -79.98% | -54.09% | -106.55% | |
| Return on Assets (ROA) | -42.29% | -32.43% | -41.70% | -40.18% | -28.98% | -51.21% | |
| Return on Capital (ROIC) | -57.56% | -41.10% | -57.89% | -48.38% | -31.70% | -60.85% | |
| Earnings Yield | -819.80% | -22.76% | -55.31% | -76.74% | -15.01% | - | |
| FCF Yield | -679.45% | -23.36% | -43.58% | -51.51% | -15.55% | - | |
| Buyback Yield / Dilution | -29.41% | -64.72% | -132.83% | -51.17% | -4150.62% | -21.66% | |
| Total Shareholder Return | -29.41% | -64.72% | -132.83% | -51.17% | -4150.62% | -21.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.